Skip to main content
Equibles
CNC logo

CNC · Centene Corp · Metrics

Track CNC — free

Use CNC with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research CNC.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$68.03 -2.14 (-3.05%) At close · Oct 26 Earnings today
S&P 500 member Russell 1000 member Rebalance outlook locked
Market Cap
$33.61B
Shares
494.00M
Volume · Oct 26 6.52M Avg daily vol (3M) 4.62M

CNC metrics

103 of 122 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$68.03
Market cap
$33.61B

Price action

20 metrics
Price change (1W)
+1.5%
Price change (30D)
+12.2%
Price change (3M)
+10.7%
Price change (6M)
+67.8%
Price change (YTD)
+70.5%
Price change (1Y)
+104.2%
Trailing year
Price change (5Y)
+1.3%
52-week high
$71.24
52-week low
$31.80
Change from 52-week high
-1.5%
Change from 52-week low
+120.7%
Annualized volatility
47.1%
Annualized volatility (3M)
32.9%
Beta
0.3
RSI (14D)
61.0
Price vs SMA 50
+6.6%
Price vs SMA 200
+28.0%
Avg volume (3M)
4.57M
Relative volume
0.9
Average dollar volume
$297.88M

Company

3 metrics
Sector
Healthcare
Industry
Healthcare Plans
Shares outstanding
494.00M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
0.1×
reciprocal yield 855.9%
EV / EBITDA
—
EV / EBIT
—
P / sales
0.2×
reciprocal yield 585.4%
P / book
1.5
reciprocal yield 65.1%
FCF yield
25.8%
TTM · current market cap
Buyback yield
0.1%
P / FCF
3.9
reciprocal yield 25.8%
P / operating cash flow
3.6
reciprocal yield 28.1%
Earnings yield
-14.7%

Historical valuation

8 metrics
P / E historical average (3Y)
27.2×
reciprocal yield 3.7%
P / E historical average (5Y)
27.2×
reciprocal yield 3.7%
EV / revenue historical average (3Y)
0.2×
reciprocal yield 590.9%
EV / revenue historical average (5Y)
0.2×
reciprocal yield 425.5%
EV / EBIT historical average (3Y)
16.3×
reciprocal yield 6.1%
EV / EBIT historical average (5Y)
18.4×
reciprocal yield 5.4%
EV / EBITDA historical average (3Y)
9.5×
reciprocal yield 10.5%
EV / EBITDA historical average (5Y)
10.7×
reciprocal yield 9.3%

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
0.1%
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
2026-10-27
Last earnings
2026-07-28

Profitability

9 metrics
Gross margin
8.0%
Operating margin
-2.8%
Trailing 12 months
Net margin
-2.5%
Gross profit (TTM)
$16.17B
Operating profit (TTM)
−$5.64B
Net income (TTM)
−$5.10B
Trailing 12 months
Diluted EPS (TTM)
$-10.35
FCF margin
4.4%
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
$411.16
Gross profit per diluted share (TTM)
$32.71
Operating profit per diluted share (TTM)
$-11.56
EBITDA per diluted share (TTM)
$-9.03
Net income per diluted share (TTM)
$-10.45
Operating cash flow per diluted share (TTM)
$19.68
Free cash flow per diluted share (TTM)
$18.06
Capital expenditures per diluted share (TTM)
$1.62
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
$0.48
Book value per share
$40.57

Growth

11 metrics
Revenue growth YoY
+9.9%
Year over year
Net income growth YoY
-301.9%
Revenue (TTM)
$202.94B
Trailing 12 months
EPS growth YoY
-314.4%
Shares change YoY
+0.8%
Year over year · more shares
Revenue CAGR (3Y)
+10.5%
Revenue CAGR (5Y)
+11.9%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
-6.3%
FCF CAGR (5Y)
-1.4%

Quality

14 metrics
Return on equity
-22.6%
Return on assets
-6.1%
Debt / equity
0.7
Current ratio
1.1
EBITDA (TTM)
−$4.39B
Free cash flow (TTM)
$8.95B
Quick ratio
1.1
Interest coverage
-8.6
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
$10.95B
Latest balance sheet
Cash & equivalents
$24.15B
Total assets
$83.01B
Total debt
$16.11B

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$9.75B
Capital expenditures (TTM)
$798.00M
R&D (TTM)
—
SG&A (TTM)
$13.02B
Stock compensation (TTM)
$236.00M
R&D / revenue
—
Stock compensation / revenue
0.1%

Ownership (13F)

9 metrics
13F filers
1,014
13F filer change QoQ
+139
Institutional ownership
102.2%
Conviction holders (share of 13F filers)
1.7%
Crowding (high-turnover and private-fund holders)
32.0%
Private-fund adviser ownership
28.5%
Active holders' share change QoQ
+0.7%
Holder tenure
17.9
Price vs estimated holder cost
+31.1%

Ownership (registered funds)

1 metrics
Index-fund ownership
22.4%

Short interest

3 metrics
Short interest
2.2%
Latest settlement · 2.5 days to cover
Days to cover
2.5d
Short-squeeze score
59 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$6.89M
Insider-sentiment score
31 / 100

Risk flags

1 metrics
Going concern
—
Key facts CIK 1071739 CUSIP 15135B101 13F (30d) 275 filings 261 filers Visit website Investor relations